Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
Epigenetic mechanisms, especially DNA methylation and histone modifications, are dynamic processes that regulate the gene expression transcriptional program in normal and diseased states. The bromodomain and extraterminal (BET) protein family (BRD2, BRD3, BRD4, and BRDT) are epigenetic readers that,...
Main Authors: | Jose Luis Morgado-Pascual, Sandra Rayego-Mateos, Lucia Tejedor, Beatriz Suarez-Alvarez, Marta Ruiz-Ortega |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01315/full |
Similar Items
-
Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins by JQ1 Unravels a Novel Epigenetic Modulation to Control Lipid Homeostasis
by: Claudia Tonini, et al.
Published: (2020-02-01) -
Defining the Mechanism of Action of Bromodomain and Extraterminal Inhibitors in Triple-Negative Breast Cancers
by: Brancato, Jennifer M.
Published: (2018) -
Bisphenol A Modulates Autophagy and Exacerbates Chronic Kidney Damage in Mice
by: Alberto Ruiz Priego, et al.
Published: (2021-07-01) -
Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
by: Adam P. Cribbs, et al.
Published: (2021-02-01) -
Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
by: Jose Luis Morgado-Pascual, et al.
Published: (2018-01-01)